BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12806695)

  • 1. [Is it possible to do pharmaco-epidemiological research using electronic databanks in the Swiss health care system?].
    Meier ChR
    Praxis (Bern 1994); 2003 May; 92(21):997-1000. PubMed ID: 12806695
    [No Abstract]   [Full Text] [Related]  

  • 2. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers.
    Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA
    BMC Res Notes; 2015 Nov; 8():634. PubMed ID: 26526064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan.
    Gau CS; Chang IS; Lin Wu FL; Yu HT; Huang YW; Chi CL; Chien SY; Lin KM; Liu MY; Wang HP
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):86-95. PubMed ID: 17006967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacoepidemiological research with large health databases].
    Andersohn F; Garbe E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1135-44. PubMed ID: 18985407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacoepidemiology. Analysis of drug prescription data].
    Gothe H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1145-54. PubMed ID: 18985408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Documentation in the cardiac catheterization laboratory using electronic databases--experiences in 176 German cath labs].
    Wiesmann F; Heinrich D; Greger H; Ertl G; Voelker W
    Z Kardiol; 2003 Jul; 92(7):571-80. PubMed ID: 12883842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [National database of German arthritis centers. Tool for health services research].
    Zink A; Huscher D; Thiele K; Listing J; Schneider M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):526-32. PubMed ID: 15221101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research by Lewis et al.
    van Staa TP; Parkinson J
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):103-4; author reply 104. PubMed ID: 18092305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Health services research based on routine data generated by the SHI].
    Swart E; Ihle P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1093-4. PubMed ID: 18985402
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmarketing surveillance and other epidemiologic uses of drug prescription data in the United States.
    Strom BL
    Ann Ist Super Sanita; 1991; 27(2):235-7. PubMed ID: 1755576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical care research based on family doctor routine data--are interface-communicated treatment data feasible?].
    Hummers-Pradier E; Simmenroth-Nayda A; Scheidt-Nave C; Scheer N; Fischer T; Niebling W; Kochen MM
    Gesundheitswesen; 2003 Feb; 65(2):109-14. PubMed ID: 12632320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Nursing Data Project in Switzerland: making nursing care visible].
    Baumberger D; Junger A; Berthou A
    Pflege Z; 2004 Feb; 57(2):117-20. PubMed ID: 15027388
    [No Abstract]   [Full Text] [Related]  

  • 14. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
    Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data.
    Gamble JM; Johnson JA; Majumdar SR; McAlister FA; Simpson SH; Eurich DT
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):551-5. PubMed ID: 23475736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validation of secondary data. Strengths and limitations].
    Hoffmann F; Andersohn F; Giersiepen K; Scharnetzky E; Garbe E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1118-26. PubMed ID: 18985405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health services research based on routine data generated by the SHI. Potential uses of health insurance fund data in health services research].
    Schubert I; Köster I; Küpper-Nybelen J; Ihle P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1095-105. PubMed ID: 18985403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Work based on data of the Gmünder Ersatzkasse. An exemplary overview].
    Grobe TG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1106-17. PubMed ID: 18985404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Eberlein-Gonska M; De Meo F
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(9-10):645-6. PubMed ID: 26699250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Public health research with statutory health insurance drug data].
    Janhsen K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):521-5. PubMed ID: 15221100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.